| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.0045 | 1 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |